Acadia believe that the number of Rett patients in the USA is 6000-9000.
From memory there are 4500 initially on the register.
Massive difference in potential revenue if the register increases to what Acadia believe the numbers are.
If Daybue can achieve a retention rate of 75%, having 4500 patients on Daybue, compared to 3000 patients is extremely significant.
Hopefully at some stage Acadia will provide numbers with their revenues. Maybe in an annual report.
Acadia believe that the number of Rett patients in the USA is...
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |